Kiora Pharmaceuticals KPRX
NASDAQ KPRX
$2.60 -0.07 (-2.62%)
At close: Sep 29, 2026 · 4:00 PM EDT

Kiora Pharmaceuticals (KPRX) Net Margin (2016 - 2024)

Updated

Kiora Pharmaceuticals' Net Margin was 22.44% in FY2024.

Analysis

Kiora Pharmaceuticals (KPRX) Net Margin (2016 - 2024) Analysis & Trends

From FY2016 onward, Kiora Pharmaceuticals has reported Net Margin for 6 years.

  • Net Margin shows a five-year change of +286.65 percentage points (FY2019 to FY2024).
  • The FY2024 figure marks the highest annual Net Margin in data going back to FY2016.
  • Per Business Quant data, Net Margin in earlier years was -56901.65% in FY2020 (-56637.44 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Kiora Pharmaceuticals 16.49 Mn 16.49 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -11,108.23%
Mar 31, 2024 84.08%
Dec 31, 2020 -9,831.62%
Mar 31, 2019 32.42%
Sep 30, 2018 -993.27%
Jun 30, 2018 -1,148.81%
Mar 31, 2018 -217.09%
Sep 30, 2017 -5,542.96%
Jun 30, 2017 -2,243.48%
Mar 31, 2017 -1,582.19%
Dec 31, 2016 -2,307.83%
Sep 30, 2016 -1,231.06%
Jun 30, 2016 -1,629.70%
API Access

Kiora Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=KPRX&period=max&api_key=YOUR_API_KEY